21 CFR 556.185
§ 556.185 Diclazuril.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 556.185, § 556.185 Diclazuril, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87757
- Permanent ID
ys:prov:87757@1- SHA-256
d96709afee34e9619cc2e3807fc15e98bc2c68e8d296d3376fc64ccecc9d53c0
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Acceptable daily intake (ADI). The ADI for total residue of diclazuril is 25 µg/kg of body weight per day.
(b) Tolerances. The tolerances for diclazuril are:
(1) Chickens and turkeys.
(i) Liver: 3 ppm.
(ii) Muscle: 0.5 ppm.
(iii) Skin/fat: 1 ppm.
(2) [Reserved]
(c) Related conditions of use. See § 558.205 of this chapter.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.